Professor David Price
Chair of Primary Care Respiratory Med
- 黑料网
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 11 of 98 Results 101 to 110 of 976
Real-World Biologic Use Patterns in Severe Asthma, 2015鈥�2021: the CLEAR Study
Pragmatic and Observational Research, vol. 16, pp. 51-66Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Adopting Australian Asthma Handbook's Option A could reduce carbon footprint
TSANZSRS 2025, pp. 11-12Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Characteristics of Asthma Patients Escalating from msICS/LABA to hsICS/LABA or msBDP/FF/G
TSANZSRS 2025, pp. 10Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
High-risk COPD patient management opportunities: Australia, US and UK comparisons
TSANZSRS 2025, pp. 19-20Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Incidence and survival of Interstitial Lung Diseases in the UK in 2010-2019
ERJ Open Research, vol. 11, no. 2, 00823-2024Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied Research
BMJ Health Care Informatics, vol. 32, no. 1, e10113Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR
Frontiers in Allergy, vol. 5, 1531788Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Characteristics of Patients with Asthma or Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and Switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone/Formoterol/Glycopyrronium (BDP/FF/G)
AAAAI / WAO Joint Congress 2025, pp. AB239Contributions to Journals: Abstracts- [ONLINE] DOI:
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD
Advances in Therapy, vol. 42, pp. 375鈥�394Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Systemic corticosteroid dose-response effects in asthma: an observational cohort study
ERJ Open Research, vol. 11, no. 1, 00172-2024Contributions to Journals: Letters- [ONLINE] DOI:
- [OPEN ACCESS]